Innate Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 797,222 | 0.986% |
Institutions | 1,757,163 | 2.17% |
Individual Insiders | 2,004,867 | 2.48% |
VC/PE Firms | 6,389,406 | 7.9% |
Public Companies | 17,303,046 | 21.4% |
General Public | 52,590,284 | 65.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,817,546 | US$23.6m | 0% | no data | |||
7,485,500 | US$18.0m | 0% | no data | |||
6,389,406 | US$15.3m | 0% | 0.08% | |||
797,222 | US$1.9m | 0% | no data | |||
739,784 | US$1.8m | 0% | no data | |||
631,088 | US$1.5m | 22.6% | no data | |||
461,757 | US$1.1m | 0% | no data | |||
230,000 | US$552.4k | 0% | 0.05% | |||
225,522 | US$541.6k | 381% | 0.02% | |||
210,228 | US$504.9k | 13.8% | no data | |||
209,000 | US$501.9k | 0% | 0.2% | |||
194,192 | US$466.4k | 25.5% | no data | |||
160,751 | US$386.1k | 0% | 0.01% | |||
140,000 | US$336.2k | 0% | 0.01% | |||
73,059 | US$175.5k | 0% | no data | |||
62,249 | US$149.5k | 54.3% | no data | |||
61,276 | US$147.2k | 0% | 1.52% | |||
58,500 | US$140.5k | 0% | 0.02% | |||
50,278 | US$120.7k | -12.5% | no data | |||
46,354 | US$111.3k | 3.11% | no data | |||
37,979 | US$91.2k | 80.1% | no data | |||
34,605 | US$83.1k | 0% | no data | |||
25,100 | US$60.3k | 0% | no data | |||
25,000 | US$60.0k | 0% | 0.02% | |||
22,705 | US$54.5k | -88.1% | no data |